| |
| |
|
| Insider
Information: |
Downs Christopher |
| Relationship: |
Director |
| City: |
Madison Heights |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
138,578 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,484 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,578 |
|
|
| Total
Value |
$17,484 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -44.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Infusystems Holdings Uts |
HAPUE |
CFO (interim) |
2017-08-14 |
28,840 |
|
0 |
Premium* |
|
|
Cns Pharmaceuticals, Inc. |
CNSP |
Chief Financial Officer |
2024-02-01 |
103,438 |
2020-08-24 |
0 |
Premium* |
|
|
EBET, Inc |
EBET |
Director |
2023-02-09 |
6,300 |
2023-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNSP |
Cns Pharmaceuticals, Inc. |
Chief Financial Officer |
• – – |
2024-02-01 |
4 |
B |
$0.30 |
$20,000 |
D/D |
66,666 |
103,438 |
2.74 |
- |
|
| CNSP |
Cns Pharmaceuticals, Inc. |
Chief Financial Officer |
• – – |
2023-08-22 |
4 |
B |
$1.27 |
$34,177 |
D/D |
27,000 |
36,772 |
2.74 |
- |
|
| CNSP |
Cns Pharmaceuticals, Inc. |
Chief Financial Officer |
• – – |
2023-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
9,772 |
0 |
- |
|
| CNSP |
Cns Pharmaceuticals, Inc. |
Chief Financial Officer |
• – – |
2023-04-17 |
4 |
B |
$3.20 |
$9,920 |
D/D |
3,100 |
9,251 |
2.74 |
- |
|
| EBET |
EBET, Inc |
Director |
– • – |
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,300 |
6,300 |
0 |
- |
|
| CNSP |
Cns Pharmaceuticals, Inc. |
Chief Financial Officer |
• – – |
2022-03-11 |
4 |
A |
$0.31 |
$10,230 |
D/D |
33,000 |
184,500 |
0 |
- |
|
| CNSP |
Cns Pharmaceuticals, Inc. |
Chief Financial Officer |
• – – |
2021-12-06 |
4 |
B |
$0.94 |
$4,702 |
D/D |
5,000 |
151,500 |
2.66 |
% |
|
| CNSP |
Cns Pharmaceuticals, Inc. |
Chief Financial Officer |
• – – |
2020-08-24 |
4 |
B |
$2.04 |
$289,680 |
D/D |
142,000 |
142,000 |
2.74 |
% |
|
| HAPUE |
Infusystems Holdings Uts |
CFO (interim) |
• – – |
2017-08-14 |
4 |
B |
$1.90 |
$15,010 |
D/D |
7,900 |
28,840 |
2.74 |
- |
|
| HAPUE |
Infusystems Holdings Uts |
CFO (interim)Officer |
• – – |
2016-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,940 |
|
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
